Association of Myosteatosis and of Graft Loss after Kidney Transplantation
Myosteatosis ascertained from existing CT scans could help identify recipients at higher risk for ACGL who may benefit most from prehabilitation.
Authors
- Mara McAdams‐DeMarco (ORCID: https://orcid.org/0000-0003-3013-925X)
- Dorry Lidor Segev (ORCID: https://orcid.org/0000-0002-1924-4801)
- Tim Swaab (ORCID: https://orcid.org/0000-0003-3564-5282)
- Omid Shafaat (ORCID: https://orcid.org/0000-0001-8793-7901)
- Stephan J. L. Bakker (ORCID: https://orcid.org/0000-0003-3356-6791)
- Clifford R. Weiss (ORCID: https://orcid.org/0000-0003-2180-1731)
- Nidhi Ghildayal (ORCID: https://orcid.org/0000-0002-7792-3431)
- Robert A. Pol (ORCID: https://orcid.org/0000-0002-2236-5233)
- Jingyao Hong (ORCID: https://orcid.org/0000-0002-8156-1306)
- Marcel Zorgdrager (ORCID: https://orcid.org/0000-0002-0345-7183)
- Alain R. Viddeleer (ORCID: https://orcid.org/0000-0002-3288-140X)
- Babak John Orandi (ORCID: https://orcid.org/0000-0001-6026-7135)
- Yi Liu (ORCID: https://orcid.org/0000-0003-1640-3501)
Institutions
- University Medical Center Groningen (NL)
- Johns Hopkins University (US)
- University of Groningen (NL)
- New York University (US)
Publication Details
- Journal
- Clinical Journal of the American Society of Nephrology
- Published
- 2025-10-15
- DOI
- https://doi.org/10.2215/cjn.0000000862
- Citations
- 2
- Primary Topic
- Renal Transplantation Outcomes and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.97